Monopar Therapeutics Inc (MNPR)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current MNPR market cap is 218.82M. The company's latest EPS is USD -1.5920 and P/E is -26.10.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.07M | -1.91M | -1.72M | -1.79M | -1.58M |
| Net Income | -1.95M | -1.81M | -1.64M | -1.72M | -1.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 122k | 0 | 0 | 0 |
| Operating Income | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
| Net Income | -4.23M | -6.31M | -9.1M | -10.5M | -8.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.59M | 7.35M | 8.91M | 7.18M | 6.07M |
| Total Liabilities | 1.98M | 1.76M | 1.44M | 1.09M | 1.12M |
| Total Equity | 6.61M | 5.59M | 7.48M | 6.09M | 4.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.35M | 16.87M | 20.52M | 13.23M | 7.35M |
| Total Liabilities | 724k | 1.18M | 1.58M | 3.14M | 1.76M |
| Total Equity | 12.63M | 15.69M | 18.94M | 10.09M | 5.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.31M | -7.86M | -1.66M | -3.33M | -4.41M |
| Investing | 1.96M | 4.93M | -983k | -986k | N/A |
| Financing | 1.69M | 2.03M | 3.18M | 3.17M | 3.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.02M | -4.66M | -7.32M | -7.23M | -7.86M |
| Investing | N/A | N/A | N/A | -4.92M | 4.93M |
| Financing | 9.35M | 8.18M | 10.88M | 33k | 2.03M |
| Market Cap | 218.82M |
| Price to Earnings Ratio | -26.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 30.18 |
| Price to Book Ratio | 39.24 |
| Dividend Yield | - |
| Shares Outstanding | 5.28M |
| Average Volume (1 week) | 57.77k |
| Average Volume (1 Month) | 50.59k |
| 52 Week Change | 2,039.32% |
| 52 Week High | 41.55 |
| 52 Week Low | 1.545 |
| Spread (Intraday) | 18.5 (37%) |
| Company Name | Monopar Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.monopartx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
